



Pharmacokinetics in Neonates and Infants 
Emiko Morita， Nobuyasu Mizuno 
Many physiological changes occur during the neonatal period and early infacy 
including changes in hepatic and renal functions， gastrointestinal mucosa and total 
f1uid volume. All these changes influence drug absorption， distribution， metabolism and 
elimination. For the determination of the dose for neonates， itis required to evaluate 
the pharmacokinetics of drugs employed. The characteristics of pharmacokinetics in 




































2 )生体内半減期 t1/2 
投与された薬物愛の50%がさ色体内から消失されるのに
察する時間を表している.





t， /?= 0.693 
げ制 Kel 
















Fluid compartment size as a function of 
Age Total body Extracellular Intr在celular
watera， fluida， f!uida， 
<3-Month fetus 92 65 25 
Term g巴station 75 35-44 33 
ふ6Months 60 23 37 
12 Months 26-30 
Puberty 60 20 40 
Adult 50 -60 20 40 














































Table 2 Apparent volume of distribution (Vd) O/kg) of various drugs as a function of age 
2. 15. 16 
Theophylline Gentamicin Kanamycin Sulfisoxazole Phenobarbital Oigoxin Lidocaine 
Premature 0.52~0.56 0.59~0. 78 0.68 4.3~ 5.7 
5~26days 0.18~ 1. 3 
25~57days O. 7~0.83 
Neonates 0.52~0.56 0.51~0.63 0.34 0.59~ 1. 54 7.5~ 9.7 1. 4~4.9 
Infants 0.16~0.83 0.35 0.81 10.2~16.3 
Children 0.20~0.68 0.29 0.61 
Adults 0.44~0.50 0.28 0.19 0.16 0.70 5 0.2~ 1. 0 
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Table 4 Comparison of binding parameters of 




Table 3 Plasma protein binding of various drugs in 
17 neonates and adults 


















旦) The results represent the me証nvalu巴土 S.0 
calculated by a non-linεar least s司uares regresslOn 
analysis using NONLIN program. b) The me註nv証lue








































































Table 5 Concentrationa) of total proteins. albumin. globulin. FFA. bilirubin and the molar ratio of FFA to 
albumin concentration in pooled sera obtained from various week-old ratsl9 






































a) Th号 valuesindicate the mean of duplicates. b) The values w号recalculated on the basis of albumin molecular 


























































o 100 200 300 400 500 
SteadY state distribution volume of inulin (ml/kg) 
Fig. 1 Correlation between steady state distribut-
ion 、I'olumeof cefazolin and extracellular water 
volume in several aged rats
20 
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Data are mean土 S.D. of 3 or 4 rats. a) Significantly differεnt from the value of 8-week-old rats at p<O.01. 
b) Significantly different from the value of 8-week-old rats at p<0.05 
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τable 7 Half四livesof various drugsl6 
Halfωlife (h) 




15~22 2.4~3.4 1. 5~5.0 
2~3 
1.7 1~ 1. 8 
36~180 12~42 33~51 
5~30 5~30 
30~50 40~60 
40~70 40~70 50~120 
2~20 12~22 18~30 
6~15 8~15 

































Time after administration (れ)
Fig. 2 Whole blood levels of phenytoin following 
intravenous administration at a doseN略 /kg24
Each point represents the mean土 S.D. of 3 rats 
Th己 pointswithout vertical bars have smaller S. D 
than the symbols. K巴y:命 l-day;ム， l-we号k;麗，



















Table 8 Pharmacokinetic parameters for phenytoin after intravenous administration to 1イ，ト，ふ and
ふweekold rats (values for parameter土 standarddeviation )24 
Parameter 
1-d-old トWeek-old 3-Week-old 8-Week-old 
(n=7j") (n=7) (nエロ7) (n=6) 
A(μg/ml) 7.69x 8.73x 9.01 x 1.40 x 
二七2.07X10-1 二七1.82x10-
1 
土4.53X10-1 こと1.64 x 10
0 
Kel(min-I) 1.15x10 …50) 8.96 X 1O-4c) 2.35 x 10 -3c) 2.63X10-2 
土1.72X10-4 二七1.34X 10-4 こ1:3.26x10-4 土1.57X10-3
Vd(ml/同)b) 1.30 X 103c) 1.15 x 103c) 1.11 X 103c) 7.17 X 102 
こと3.51XI0
1
二七2.40X 101 土5.58x101 二七8.42X 101 
CL (ml/ min/kg) 1.49 x 10-2c) 1.03 X 100c) 2.61 X 10Oc) 1.89 X 101 
土2.24XI0-1 土1.55XI0-1 土3.85X 10-1 土2.49x 100 
a) Number of input data， each of which is the mean of 3 rats. b) Vd (ml/kg)=(Dose)/ A c) Significantly 
different from the values of 8-week-old rats at p<O.01. 
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